Involvement of the spinal γ-aminobutyric acid receptor in the analgesic effects of intrathecally injected hypertonic saline in spinal nerve-ligated rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Hypertonic saline is used for treating chronic pain; however, clinical studies that aid in optimizing therapeutic protocols are lacking. We aimed to determine the concentration of intrathecally injected hypertonic saline at which the effect reaches its peak as well as the underlying γ-aminobutyric acid (GABA) receptor-related antinociceptive mechanism. Methods: Spinal nerve ligation (SNL; left L5 and L6) was performed to induce neuropathic pain in rats weighing 250–300 g. Experiment 1: one week after implanting the intrathecal catheter, 60 rats were assigned randomly to intrathecal injection with 0.45%, 0.9%, 2.5%, 5%, 10%, and 20% NaCl, followed by behavioral testing at baseline and after 30 minutes, 2 hours, 1 day, and 1 week to determine the minimal concentration which produced maximal analgesia. Experiment 2: after determining the optimal intrathecal hypertonic saline concentration, 60 rats were randomly divided into four groups: Sham, hypertonic saline without pretreatment, and hypertonic saline after pretreatment with one of two GABA receptor antagonists (GABAA [bicuculline], or GABAB [phaclofen]). Behavioral tests were performed at weeks 1 and 3 following each treatment. Results: Hypertonic saline at concentrations greater than 5% alleviated SNL-induced mechanical allodynia and had a significant therapeutic effect, while showing a partial time- and dose-dependent antinociceptive effect on thermal and cold hyperalgesia. However, pretreatment with GABA receptor antagonists inhibited the antinociceptive effect of 5% NaCl. Conclusions: This study indicates that the optimal concentration of hypertonic saline for controlling mechanical allodynia in neuropathic pain is 5%, and that its analgesic effect is related to GABAA and GABAB receptors.
Abstract
Background: Hypertonic saline is used for treating chronic pain; however, clinical studies that aid in optimizing therapeutic protocols are lacking. We aimed to determine the concentration of intrathecally injected hypertonic saline at which the effect reaches its peak as well as the underlying γ-aminobutyric acid (GABA) receptor-related antinociceptive mechanism. Methods: Spinal nerve ligation (SNL; left L5 and L6) was performed to induce neuropathic pain in rats weighing 250–300 g. Experiment 1: one week after implanting the intrathecal catheter, 60 rats were assigned randomly to intrathecal injection with 0.45%, 0.9%, 2.5%, 5%, 10%, and 20% NaCl, followed by behavioral testing at baseline and after 30 minutes, 2 hours, 1 day, and 1 week to determine the minimal concentration which produced maximal analgesia. Experiment 2: after determining the optimal intrathecal hypertonic saline concentration, 60 rats were randomly divided into four groups: Sham, hypertonic saline without pretreatment, and hypertonic saline after pretreatment with one of two GABA receptor antagonists (GABAA [bicuculline], or GABAB [phaclofen]). Behavioral tests were performed at weeks 1 and 3 following each treatment. Results: Hypertonic saline at concentrations greater than 5% alleviated SNL-induced mechanical allodynia and had a significant therapeutic effect, while showing a partial time- and dose-dependent antinociceptive effect on thermal and cold hyperalgesia. However, pretreatment with GABA receptor antagonists inhibited the antinociceptive effect of 5% NaCl. Conclusions: This study indicates that the optimal concentration of hypertonic saline for controlling mechanical allodynia in neuropathic pain is 5%, and that its analgesic effect is related to GABAA and GABAB receptors.
참고문헌 (40)
- Hitchcock E, "Osmolytic neurolysis for intractable facial pain", Lancet, 1, pp.434~436 (1969)
- Hitchcock E, "Hypertonic saline in management of intractable pain", Lancet, 1, pp.310~312 (1973)
- Lucas JT, "Adverse reactions to intrathecal saline injection for control of pain", J Neurosurg, 42, pp.557~561 (1975)
- Thompson GE, "Pulmonary edema complicating intrathecal hypertonic saline injection for intractable pain", Anesthesiology, 35, pp.425~427 (1971)
- Racz GB, "Techniques of neurolysis", pp.73~86 (1989), Springer US
- Joo EY, "Efficacy of adjuvant 10% hypertonic saline in transforaminal epidural steroid injection : a retrospective analysis", Pain Physician, 20, pp.E107~E114 (2017)
- Koh WU, "Transforaminal hypertonic saline for the treatment of lumbar lateral canal stenosis : a doubleblinded, randomized, active-control trial", Pain Physician, 16, pp.197~211 (2013)
- Lee Y, "Adjuvant administration of hypertonic saline in lumbar epidural intervention may be associated with successful response in patients with probable neuropathic radicular pain Screened by Douleur Neuropathique 4", Int J Med Sci, 18, pp.2736~2742 (2021)
- Myong-Hwan Karm, "Effectiveness of percutaneous epidural neuroplasty using a balloon catheter in patients with chronic spinal stenosis accompanying mild spondylolisthesis: a longitudinal cohort study", The Korean Journal of Pain, 36(2), pp.184~194 (2023), 대한통증학회[DOI]
- Heavner JE, "Percutaneous epidural neuroplasty : prospective evaluation of 0. 9% NaCl versus 10% NaCl with or without hyaluronidase", Reg Anesth Pain Med, 24, pp.202~207 (1999)
- Manchikanti L, "One day lumbar epidural adhesiolysis and hypertonic saline neurolysis in treatment of chronic low back pain : a randomized, double-blind trial", Pain Physician, 7, pp.177~186 (2004)
- Choi EJ, "A retrospective study to evaluate the effect of concentration of hypertonic saline on efficacy and safety of epidural adhesiolysis", Anesth Analg, 124, pp.2021~2029 (2017)
- Frank Lee, "Epidural Lysis of Adhesions", The Korean Journal of Pain, 27(1), pp.3~15 (2014), 대한통증학회
- Watanabe M, "GABA and GABA receptors in the central nervous system and other organs", Int Rev Cytol, 213, pp.1~47 (2002)
- Jensen ML, "The beta subunit determines the ion selectivity of the GABAA receptor", J Biol Chem, 277, pp.41438~41447 (2002)
- Sieghart W, "Subunit composition, distribution and function of GABA(A)receptor subtypes", Curr Top Med Chem, 2, pp.795~816 (2002)
- Price TJ, "Chloride regulation in the pain pathway", Brain Res Rev, 60, pp.149~170 (2009)
- Sung Hoon Kim, "Tumor Necrosis Factor-alpha and Apoptosis Following Spinal Nerve Ligation Injury in Rats", The Korean Journal of Pain, 24(4), pp.185~190 (2011), 대한통증학회
- Kim SH, "An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat", Pain, 50, pp.355~363 (1992)
- Yaksh TL, "Chronic catheterization of the spinal subarachnoid space", Physiol Behav, 17, pp.1031~1036 (1976)
- Chaplan SR, "Quantitative assessment of tactile allodynia in the rat paw", J Neurosci Methods, 53, pp.55~63 (1994)
- Li Y, "Mechanical hyperalgesia after an L5 spinal nerve lesion in the rat is not dependent on input from injured nerve fibers", Pain, 85, pp.493~502 (2000)
- Deuis JR, "Methods used to evaluate pain behaviors in rodents", Front Mol Neurosci, 10, pp.284~ (2017)
- Biella GE, "Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine", J Neurotrauma, 20, pp.593~601 (2003)
- Malan TP, "Spinal GABA(A)and GABA(B)receptor pharmacology in a rat model of neuropathic pain", Anesthesiology, 96, pp.1161~1167 (2002)
- Hara K, "Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model", Eur J Pharmacol, 723, pp.459~464 (2014)
- Hitchcock E, "Hypothermic subarachnoid irrigation for intractable pain", Lancet, 1, pp.1133~1135 (1967)
- King JS, "Differential blockade of cat dorsal root C fibers by various chloride solutions", J Neurosurg, 36, pp.569~583 (1972)
- Anderson SR, "Evolution of epidural lysis of adhesions", Pain Physician, 3, pp.262~270 (2000)
- Gerdesmeyer L, "Percutaneous epidural lysis of adhesions in chronic lumbar radicular pain : a randomized, double-blind, placebo-controlled trial", Pain Physician, 16, pp.185~196 (2013)
- Jewett DL, "Conduction block of monkey dorsal rootlets by water and hypertonic saline solutions", Exp Neurol, 33, pp.225~237 (1971)
- Enna SJ, "The role of GABA in the mediation and perception of pain", Adv Pharmacol, 54, pp.1~27 (2006)
- Zeilhofer HU, "Chronic pain states : pharmacological strategies to restore diminished inhibitory spinal pain control", Annu Rev Pharmacol Toxicol, 52, pp.111~133 (2012)
- Hwang JH, "The effect of spinal GABA receptor agonists on tactile allodynia in a surgicallyinduced neuropathic pain model in the rat", Pain, 70, pp.15~22 (1997)
- Sokal DM, "Effects of spinal administration of muscimol on C-and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats", Brain Res, 962, pp.213~220 (2003)
- Loomis CW, "Coadministration of intrathecal strychnine and bicuculline effects synergistic allodynia in the rat : an isobolographic analysis", J Pharmacol Exp Ther, 296, pp.756~761 (2001)
- Anseloni VC, "Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat", J Pain, 9, pp.732~738 (2008)
- Sivilotti L, "The contribution of GABAA and glycine receptors to central sensitization : disinhibition and touch-evoked allodynia in the spinal cord", J Neurophysiol, 72, pp.169~179 (1994)
- Caba M, "Perispinal progestins enhance the antinociceptive effects of muscimol in the rat", Pharmacol Biochem Behav, 47, pp.177~182 (1994)
- Dirig DM, "Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model", J Pharmacol Exp Ther, 275, pp.219~227 (1995)